These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1534 related items for PubMed ID: 20513456

  • 1. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 2. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [Abstract] [Full Text] [Related]

  • 3. [SSRIs and pregnancy: a review of the literature].
    Soufia M, Aoun J, Gorsane MA, Krebs MO.
    Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
    [Abstract] [Full Text] [Related]

  • 4. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 5. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN, Bos AF.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2873-4. PubMed ID: 18257430
    [Abstract] [Full Text] [Related]

  • 6. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
    Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M.
    J Clin Psychopharmacol; 2012 Apr 29; 32(2):186-94. PubMed ID: 22367660
    [Abstract] [Full Text] [Related]

  • 7. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S, Bellantuono C.
    J Clin Psychiatry; 2009 Mar 29; 70(3):414-22. PubMed ID: 19254517
    [Abstract] [Full Text] [Related]

  • 8. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 9. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
    Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.
    Clin Ther; 2007 May 29; 29(5):918-926. PubMed ID: 17697910
    [Abstract] [Full Text] [Related]

  • 10. SSRI antidepressants and persistent pulmonary hypertension in newborns.
    Prescrire Int; 2008 Aug 29; 17(96):156. PubMed ID: 19492488
    [Abstract] [Full Text] [Related]

  • 11. Safety of selective serotonin reuptake inhibitors in pregnancy.
    Alwan S, Friedman JM.
    CNS Drugs; 2009 Aug 29; 23(6):493-509. PubMed ID: 19480468
    [Abstract] [Full Text] [Related]

  • 12. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].
    Watanabe O.
    Seishin Shinkeigaku Zasshi; 2014 Aug 29; 116(12):996-1004. PubMed ID: 25823351
    [Abstract] [Full Text] [Related]

  • 13. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V, Ververs TF, Visser GH, Gazzolo D.
    Curr Med Chem; 2012 Aug 29; 19(27):4554-61. PubMed ID: 22876893
    [Abstract] [Full Text] [Related]

  • 14. [Antidepressants-SSRIs in pregnancy and risk of major malformations: treat or not to treat].
    Bellantuono C, Santone G.
    Recenti Prog Med; 2014 Jun 29; 105(6):254-61. PubMed ID: 25002286
    [Abstract] [Full Text] [Related]

  • 15. Antidepressants in pregnancy: a systematic review.
    Udechuku A, Nguyen T, Hill R, Szego K.
    Aust N Z J Psychiatry; 2010 Nov 29; 44(11):978-96. PubMed ID: 21034181
    [Abstract] [Full Text] [Related]

  • 16. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
    Malm H.
    Ther Drug Monit; 2012 Dec 29; 34(6):607-14. PubMed ID: 23042258
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period.
    McDonagh M, Matthews A, Phillipi C, Romm J, Peterson K, Thakurta S, Guise JM.
    Evid Rep Technol Assess (Full Rep); 2014 Jul 29; (216):1-308. PubMed ID: 30313002
    [Abstract] [Full Text] [Related]

  • 18. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
    Gentile S.
    Expert Opin Drug Metab Toxicol; 2015 Jul 29; 11(10):1585-97. PubMed ID: 26135630
    [Abstract] [Full Text] [Related]

  • 19. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT.
    Br J Clin Pharmacol; 2008 Apr 29; 65(4):600-6. PubMed ID: 17953715
    [Abstract] [Full Text] [Related]

  • 20. Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.
    Ornoy A, Koren G.
    Semin Fetal Neonatal Med; 2014 Jun 29; 19(3):188-94. PubMed ID: 24321501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.